share_log
Reuters ·  Jul 26, 2024 09:00
Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting With SeaStar Medical’s Quelimmune™ Therapy at Cincinnati Children’s
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment